Most eligible patients will pay $18 with the savings card
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced a new patient support program for NEXIUM. The NEXIUM Savings Card is designed to offer eligible patients instant discounts on their prescriptions for NEXIUM, potentially saving the patient up to $600 annually.1
When using the NEXIUM Savings Card, eligible patients can instantly save up to $50, with most paying $18 each on up to 12 prescriptions of NEXIUM.* Additionally, eligible patients with no prescription insurance coverage can save $50 instantly.*1
NEXIUM Savings Card Examples
- Those with commercial insurance
- Those paying cash for their prescription will save $50 on each prescription up to 12 times.
The NEXIUM Savings Card does not require activation or program enrollment.1 After speaking with their health care provider and checking eligibility, patients can obtain the savings card from their doctor, by downloading one from purplepill.com, or by calling 1-800-503-9880, Monday through Friday from 8 a.m. to 6 p.m. ET.
*Eligibility: The offer is good for up to $50 off on 12 prescriptions of at least a 30-day supply of NEXIUM. The offer is not valid if your copay is $18 or less. The card must be used within 14 months of the first prescription fill and cannot be combined with any other offer. The offer is void for mail order and for patients covered by Medicaid, Medicare, or similar state or federal programs and is void where prohibited by law, taxed or restricted. The offer is not valid for residents of MA. The card is limited to one per person and is not transferable. The offer is good only in the U.S. and its territories. AstraZeneca reserves the right to discontinue the offer at any time. At the time of purchase, present the card to the pharmacist along with your insurance card and a valid prescription for NEXIUM (esomeprazole magnesium).
Important Safety Information about NEXIUM
- Symptom relief does not rule out the presence of other serious stomach conditions
- Talk to your doctor about your risk for:
- bone fractures if you take multiple daily doses of NEXIUM for a long period of time
- low magnesium levels if you take NEXIUM for a long period of time
- Tell your doctor about all of the medicines you take including prescription and non-prescription drugs, vitamins, and herbal supplements. NEXIUM may affect how other medicines work, and other medicines may affect how NEXIUM works
- Side effects with NEXIUM include headache, diarrhea, and abdominal pain
Approved Uses for NEXIUM
NEXIUM is prescribed to treat the symptoms of acid reflux disease, which typically include persistent heartburn on 2 or more days per week, despite treatment and change of diet.
For many people, NEXIUM is also prescribed to heal damage to the esophagus called erosive esophagitis. This damage may be caused over time from stomach acid wearing away the lining of the esophagus. Only a doctor can diagnose this condition. With NEXIUM, most erosions heal in 4 to 8 weeks. Your results with NEXIUM may vary.
Please read the full Prescribing Information and discuss it with your doctor or health care professional.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).
NEXIUM is a registered trademark of the AstraZeneca group of companies.
1 Atlas # 1245901: Wolters Kluwer Pharma Solutions, Dynamic Claims, six months ending March 2011. Accessed on May 23, 2011.
Blair Hains, +1-302-885-1813
KEYWORDS: United States North America Delaware
INDUSTRY KEYWORDS: Seniors Women Health Pharmaceutical Consumer General Health Men